I M van der Steenstraten, A Tibben, R A Roos, J J van de Kamp, M F Niermeijer. Am J Hum Genet 1994
Times Cited: 104
Times Cited: 104
Times Cited
Times Co-cited
Similarity
The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.
S Wiggins, P Whyte, M Huggins, S Adam, J Theilmann, M Bloch, S B Sheps, M T Schechter, M R Hayden. N Engl J Med 1992
S Wiggins, P Whyte, M Huggins, S Adam, J Theilmann, M Bloch, S B Sheps, M T Schechter, M R Hayden. N Engl J Med 1992
39
Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners.
A Tibben, R Timman, E C Bannink, H J Duivenvoorden. Health Psychol 1997
A Tibben, R Timman, E C Bannink, H J Duivenvoorden. Health Psychol 1997
34
Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. J Med Genet 1996
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. J Med Genet 1996
32
Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates.
M Bloch, M Fahy, S Fox, M R Hayden. Am J Med Genet 1989
M Bloch, M Fahy, S Fox, M R Hayden. Am J Med Genet 1989
32
Non-participation in predictive testing for Huntington's disease: individual decision-making, personality and avoidant behaviour in the family.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, T Cloostermans, J J Cassiman, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Eur J Hum Genet 1997
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, T Cloostermans, J J Cassiman, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Eur J Hum Genet 1997
55
Presymptomatic DNA testing for Huntington disease: identifying the need for psychological intervention.
A Tibben, H J Duivenvoorden, M Vegter-van der Vlis, M F Niermeijer, P G Frets, J J van de Kamp, R A Roos, H G Rooijmans, F Verhage. Am J Med Genet 1993
A Tibben, H J Duivenvoorden, M Vegter-van der Vlis, M F Niermeijer, P G Frets, J J van de Kamp, R A Roos, H G Rooijmans, F Verhage. Am J Med Genet 1993
37
On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program.
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegtervan der Vlis, R A Roos, H G Rooymans, G J van Ommen, F Verhage. Am J Med Genet 1993
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegtervan der Vlis, R A Roos, H G Rooymans, G J van Ommen, F Verhage. Am J Med Genet 1993
28
Exploration of the effects of predictive testing for Huntington disease on intimate relationships.
K A Quaid, M K Wesson. Am J Med Genet 1995
K A Quaid, M K Wesson. Am J Med Genet 1995
36
Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program.
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegter-van der Vlis, R A Roos, G J van Ommen, H J Duivenvoorden, F Verhage. Am J Med Genet 1993
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegter-van der Vlis, R A Roos, G J van Ommen, H J Duivenvoorden, F Verhage. Am J Med Genet 1993
32
Self-selection in predictive testing for Huntington's disease.
A M Codori, R Hanson, J Brandt. Am J Med Genet 1994
A M Codori, R Hanson, J Brandt. Am J Med Genet 1994
26
Predictive testing for Huntington's disease: risk perception, reasons for testing and psychological profile of test applicants.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Genet Couns 1995
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Genet Couns 1995
36
A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.
E W Almqvist, M Bloch, R Brinkman, D Craufurd, M R Hayden. Am J Hum Genet 1999
E W Almqvist, M Bloch, R Brinkman, D Craufurd, M R Hayden. Am J Hum Genet 1999
24
Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium.
P S Harper, C Lim, D Craufurd. J Med Genet 2000
P S Harper, C Lim, D Craufurd. J Med Genet 2000
24
Psychological impact of genetic testing for Huntington's disease: an update of the literature.
B Meiser, S Dunn. J Neurol Neurosurg Psychiatry 2000
B Meiser, S Dunn. J Neurol Neurosurg Psychiatry 2000
23
Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. The Canadian Collaborative Study Predictive Testing.
K Lawson, S Wiggins, T Green, S Adam, M Bloch, M R Hayden. J Med Genet 1996
K Lawson, S Wiggins, T Green, S Adam, M Bloch, M R Hayden. J Med Genet 1996
34
Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program.
A Tibben, H J Duivenvoorden, M F Niermeijer, M Vegter-van der Vlis, R A Roos, F Verhage. Psychosom Med 1994
A Tibben, H J Duivenvoorden, M F Niermeijer, M Vegter-van der Vlis, R A Roos, F Verhage. Psychosom Med 1994
37
Psychological costs and benefits of predictive testing for Huntington's disease.
A M Codori, J Brandt. Am J Med Genet 1994
A M Codori, J Brandt. Am J Med Genet 1994
21
A polymorphic DNA marker genetically linked to Huntington's disease.
J F Gusella, N S Wexler, P M Conneally, S L Naylor, M A Anderson, R E Tanzi, P C Watkins, K Ottina, M R Wallace, A Y Sakaguchi. Nature 1983
J F Gusella, N S Wexler, P M Conneally, S L Naylor, M A Anderson, R E Tanzi, P C Watkins, K Ottina, M R Wallace, A Y Sakaguchi. Nature 1983
20
Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.
M Huggins, M Bloch, S Wiggins, S Adam, O Suchowersky, M Trew, M Klimek, C R Greenberg, M Eleff, L P Thompson. Am J Med Genet 1992
M Huggins, M Bloch, S Wiggins, S Adam, O Suchowersky, M Trew, M Klimek, C R Greenberg, M Eleff, L P Thompson. Am J Med Genet 1992
20
Uptake of presymptomatic predictive testing for Huntington's disease.
D Craufurd, A Dodge, L Kerzin-Storrar, R Harris. Lancet 1989
D Craufurd, A Dodge, L Kerzin-Storrar, R Harris. Lancet 1989
19
Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
19
DNA-testing for Huntington's disease in The Netherlands: a retrospective study on psychosocial effects.
A Tibben, M Vegter-van der Vlis, M I Skraastad, P G Frets, J J van der Kamp, M F Niermeijer, G J van Ommen, R A Roos, H G Rooijmans, D Stronks. Am J Med Genet 1992
A Tibben, M Vegter-van der Vlis, M I Skraastad, P G Frets, J J van der Kamp, M F Niermeijer, G J van Ommen, R A Roos, H G Rooijmans, D Stronks. Am J Med Genet 1992
25
29
Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.
A C DudokdeWit, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier. J Med Genet 1998
A C DudokdeWit, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier. J Med Genet 1998
24
Predictive testing for Huntington's disease with use of a linked DNA marker.
G J Meissen, R H Myers, C A Mastromauro, W J Koroshetz, K W Klinger, L A Farrer, P A Watkins, J F Gusella, E D Bird, J B Martin. N Engl J Med 1988
G J Meissen, R H Myers, C A Mastromauro, W J Koroshetz, K W Klinger, L A Farrer, P A Watkins, J F Gusella, E D Bird, J B Martin. N Engl J Med 1988
18
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
17
The measurement of pessimism: the hopelessness scale.
A T Beck, A Weissman, D Lester, L Trexler. J Consult Clin Psychol 1974
A T Beck, A Weissman, D Lester, L Trexler. J Consult Clin Psychol 1974
17
Partners of Huntington patients: implications of the disease and opinions about predictive testing and prenatal diagnosis.
G Evers-Kiebooms, A Swerts, H Van Den Berghe. Genet Couns 1990
G Evers-Kiebooms, A Swerts, H Van Den Berghe. Genet Couns 1990
68
Paradox of a better test for Huntington's disease.
A Maat-Kievit, M Vegter-van der Vlis, M Zoeteweij, M Losekoot, A van Haeringen, R Roos. J Neurol Neurosurg Psychiatry 2000
A Maat-Kievit, M Vegter-van der Vlis, M Zoeteweij, M Losekoot, A van Haeringen, R Roos. J Neurol Neurosurg Psychiatry 2000
27
Invited essay on the psychological aspects of genetic counseling. V. Preselection: a family coping strategy in Huntington disease.
S Kessler. Am J Med Genet 1988
S Kessler. Am J Med Genet 1988
30
16
Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: comparing questionnaire results with in-depth interviews. Rotterdam/Leiden Genetics Workgroup.
A C DudokdeWit, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier, R W Trijsburg. Am J Med Genet 1998
A C DudokdeWit, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier, R W Trijsburg. Am J Med Genet 1998
25
Psychological functioning before predictive testing for Huntington's disease: the role of the parental disease, risk perception, and subjective proximity of the disease.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns. J Med Genet 1999
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns. J Med Genet 1999
40
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
15
Predictive testing for Huntington's disease: a challenge for persons at risk and for professionals.
G Evers-Kiebooms, M Decruyenaere. Patient Educ Couns 1998
G Evers-Kiebooms, M Decruyenaere. Patient Educ Couns 1998
20
Reluctance to undergo predictive testing: the case of Huntington disease.
K A Quaid, M Morris. Am J Med Genet 1993
K A Quaid, M Morris. Am J Med Genet 1993
15
Predictive testing for Huntington disease: I. Description of a pilot project in British Columbia.
S Fox, M Bloch, M Fahy, M R Hayden. Am J Med Genet 1989
S Fox, M Bloch, M Fahy, M R Hayden. Am J Med Genet 1989
15
Presymptomatic testing for huntington diseases: Recommendations for counseling.
K A Quaid. J Genet Couns 1992
K A Quaid. J Genet Couns 1992
42
35
Age at onset in Huntington's disease: effect of line of inheritance and patient's sex.
R A Roos, M Vegter-van der Vlis, J Hermans, H M Elshove, A C Moll, J J van de Kamp, G W Bruyn. J Med Genet 1991
R A Roos, M Vegter-van der Vlis, J Hermans, H M Elshove, A C Moll, J J van de Kamp, G W Bruyn. J Med Genet 1991
17
Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.
J D Brook, M E McCurrach, H G Harley, A J Buckler, D Church, H Aburatani, K Hunter, V P Stanton, J P Thirion, T Hudson. Cell 1992
J D Brook, M E McCurrach, H G Harley, A J Buckler, D Church, H Aburatani, K Hunter, V P Stanton, J P Thirion, T Hudson. Cell 1992
14
Impact of Event Scale: a cross-validation study and some empirical evidence supporting a conceptual model of stress response syndromes.
N J Zilberg, D S Weiss, M J Horowitz. J Consult Clin Psychol 1982
N J Zilberg, D S Weiss, M J Horowitz. J Consult Clin Psychol 1982
14
The motivation of at-risk individuals and their partners in deciding for or against predictive testing for Huntington's disease.
G Evers-Kiebooms, A Swerts, J J Cassiman, H Van den Berghe. Clin Genet 1989
G Evers-Kiebooms, A Swerts, J J Cassiman, H Van den Berghe. Clin Genet 1989
22
Predictors of psychological adjustment to genetic testing for Huntington's disease.
A M Codori, P R Slavney, C Young, D L Miglioretti, J Brandt. Health Psychol 1997
A M Codori, P R Slavney, C Young, D L Miglioretti, J Brandt. Health Psychol 1997
20
Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk.
M Bloch, S Adam, S Wiggins, M Huggins, M R Hayden. Am J Med Genet 1992
M Bloch, S Adam, S Wiggins, M Huggins, M R Hayden. Am J Med Genet 1992
13
A diagnostic interview: the schedule for affective disorders and schizophrenia.
J Endicott, R L Spitzer. Arch Gen Psychiatry 1978
J Endicott, R L Spitzer. Arch Gen Psychiatry 1978
13
Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy.
J Buxton, P Shelbourne, J Davies, C Jones, T Van Tongeren, C Aslanidis, P de Jong, G Jansen, M Anvret, B Riley. Nature 1992
J Buxton, P Shelbourne, J Davies, C Jones, T Van Tongeren, C Aslanidis, P de Jong, G Jansen, M Anvret, B Riley. Nature 1992
13
Developmental tasks of childhood and adolescence: implications for genetic testing.
J H Fanos. Am J Med Genet 1997
J H Fanos. Am J Med Genet 1997
13
Attitudes of persons at risk for Huntington disease toward predictive testing.
S Kessler, T Field, L Worth, H Mosbarger. Am J Med Genet 1987
S Kessler, T Field, L Worth, H Mosbarger. Am J Med Genet 1987
12
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.